β1 integrin deletion enhances progression of prostate cancer in the TRAMP mouse model

被引:16
|
作者
Moran-Jones, Kim [1 ]
Ledger, Anita [1 ]
Naylor, Matthew J. [1 ,2 ,3 ]
机构
[1] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
[2] Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia
[3] Univ Sydney, Sch Med Sci, Bosch Inst, Sydney, NSW 2006, Australia
来源
SCIENTIFIC REPORTS | 2012年 / 2卷
基金
英国医学研究理事会;
关键词
BETA(1A) INTEGRIN EXPRESSION; ALPHA(2)BETA(1) INTEGRIN; TERMINAL DIFFERENTIATION; 3-DIMENSIONAL CULTURES; CELL-PROLIFERATION; TRANSGENIC MOUSE; MAMMARY-GLAND; IN-VIVO; GROWTH; PROTEIN;
D O I
10.1038/srep00526
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
beta 1 integrin regulates the response of both normal and cancer cells to their local environment. Although mis-localised in prostate cancer, the role beta 1 integrin plays in prostate development and carcinogenesis remains unknown. To assess the role of beta 1 integrin in vivo, we conditionally deleted beta 1 integrin from prostate epithelium and subsequently crossed these mice to the TRAMP prostate carcinogenesis model. Deletion of beta 1 integrin following castration and subsequent androgen supplementation resulted in an expansion of the p63-positive basal cell population and decreased differentiation. Consistent with these findings, deletion of beta 1 integrin in TRAMP mice decreased animal survival, decreased retention of normal prostate morphology, increased the percentage of tissue with poorly differentiated carcinoma, and increased cell proliferation. This study demonstrates that beta 1 integrin regulates several aspects of normal prostate development and in contrast to its role in several other tissues, its loss is associated with increased rates of prostate tumour progression.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling
    Deeb, Dorrah
    Gao, Xiaohua
    Liu, Yongbo
    Jiang, Daniel
    Divine, GeorgeW.
    Arbab, Ali S.
    Dulchavsky, Scott A.
    Gautam, Subhash C.
    CARCINOGENESIS, 2011, 32 (05) : 757 - 764
  • [22] A Western-Type Diet Accelerates Tumor Progression in an Autochthonous Mouse Model of Prostate Cancer
    Llaverias, Gemma
    Danilo, Christiane
    Wang, Yu
    Witkiewicz, Agnes K.
    Daumer, Kristin
    Lisanti, Michael P.
    Frank, Philippe G.
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 177 (06): : 3180 - 3191
  • [23] Icaritin reduces prostate cancer progression via inhibiting high-fat diet-induced serum adipokine in TRAMP mice model
    Wu, Xiaobo
    Long, Xingbo
    Yang, Chen
    Chen, Huan
    Sharkey, Christina
    Rashid, Khalid
    Hu, Mengbo
    Liu, Yufei
    Huang, Qi
    Chen, Qi
    Hu, Jimeng
    Jiang, Haowen
    JOURNAL OF CANCER, 2020, 11 (22): : 6556 - 6564
  • [24] Inducible shRNA expression for application in a prostate cancer mouse model
    Czauderna, F
    Santel, A
    Hinz, M
    Fechtner, M
    Durieux, B
    Fisch, G
    Leenders, F
    Arnold, W
    Giese, K
    Klippel, A
    Kaufmann, J
    NUCLEIC ACIDS RESEARCH, 2003, 31 (21)
  • [25] Dysfunctional Transforming Growth Factor-β Receptor II Accelerates Prostate Tumorigenesis in the TRAMP Mouse Model
    Pu, Hong
    Collazo, Joanne
    Jones, Elisabeth
    Gayheart, Dustin
    Sakamoto, Shinichi
    Vogt, Adam
    Mitchell, Bonnie
    Kyprianou, Natasha
    CANCER RESEARCH, 2009, 69 (18) : 7366 - 7374
  • [26] CCL-4 enhances prostate cancer migration and invasion by modulating integrin expression
    Rohena-Rivera, Krizia
    Sanchez-Vazquez, Maria M.
    Aponte-Colon, Diana A.
    Forestier-Roman, Ingrid S.
    Quintero-Aguilo, Mario E.
    Martinez-Ferrer, Magaly
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (03): : 5426 - 5438
  • [27] CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model
    Domanska, Urszula M.
    Boer, Jennifer C.
    Timmer-Bosscha, Hetty
    van Vugt, Marcel A. T. M.
    Hoving, Hilde D.
    Kliphuis, Nathalie M.
    Rosati, Stefano
    van der Poel, Henk G.
    de Jong, Igle Jan
    de Vries, Elisabeth G. E.
    Walenkamp, Annemiek M. E.
    CLINICAL & EXPERIMENTAL METASTASIS, 2014, 31 (07) : 829 - 839
  • [28] CAVEOLIN-1 AND PROSTATE CANCER PROGRESSION
    Freeman, Michael R.
    Yang, Wei
    Di Vizio, Dolores
    CAVEOLINS AND CAVEOLAE: ROLES IN SIGNALING AND DISEASE MECHANISMS, 2012, 729 : 95 - 110
  • [29] Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer
    Xu, Peng
    Xu, Naijin
    Guo, Kai
    Xu, Abai
    Takenaka, Fumiaki
    Matsuura, Eiji
    Liu, Chunxiao
    Kumon, Hiromi
    Huang, Peng
    ONCOTARGET, 2016, 7 (22) : 33025 - 33034
  • [30] Human Prostate Cancer in a Clinically Relevant Xenograft Mouse Model: Identification of β(1,6)-Branched Oligosaccharides as a Marker of Tumor Progression
    Lange, Tobias
    Ullrich, Sebastian
    Mueller, Imke
    Nentwich, Michael F.
    Stuebke, Katrin
    Feldhaus, Susanne
    Knies, Christine
    Hellwinkel, Olaf J. C.
    Vessella, Robert L.
    Abramjuk, Claudia
    Anders, Mario
    Schroeder-Schwarz, Jennifer
    Schlomm, Thorsten
    Huland, Hartwig
    Sauter, Guido
    Schumacher, Udo
    CLINICAL CANCER RESEARCH, 2012, 18 (05) : 1364 - 1373